Articles tagged with 'judong-yang-2121564' | Cedars-Sinai Medical Center

Hispanic and Black patients are less likely than white patients to receive treatments known to cure a type of liver cancer called intrahepatic cholangiocarcinoma (iCCA), according to a new study by Cedars-Sinai Cancer investigators. Published in Canc...

Cedars-Sinai Cancer investigators have created a blood test that uses a technology made commonly available during the COVID-19 pandemic to detect the most common form of liver cancer—at an early enough stage that cure is possible. Their work was publ...

Ju Dong Yang, MD, a liver cancer clinician-researcher who studies epidemiology, health disparities and outcomes, and biomarkers both nationally and globally, has been appointed medical director of the Liver Cancer Program at Cedars-Sinai Cancer.In hi...